$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Recent advances in detection technologies for COVID-19 원문보기

Talanta, v.233, 2021년, pp.122609 -   

Han, Tingting (Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University) ,  Cong, Hailin (Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University) ,  Shen, Youqing (Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University) ,  Yu, Bing (Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University)

Abstract AI-Helper 아이콘AI-Helper

Abstract Corona Virus Disease 2019 (COVID-19) is a highly infectious respiratory illness that was caused by the SARS-CoV-2. It spread around the world in just a few months and became a worldwide pandemic. Quick and accurate diagnosis of infected patients is very important for controlling transmissi...

주제어

참고문헌 (124)

  1. 1 Abd El-Aziz T.M. Stockand J.D. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status Infect. Genet. Evol. 83 2020 104327 10.1016/j.meegid.2020.104327 32320825 

  2. 2 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Zhang L. Fan G. Xu J. Gu X. Cheng Z. Yu T. Xia J. Wei Y. Wu W. Xie X. Yin W. Li H. Liu M. Xiao Y. Gao H. Guo L. Xie J. Wang G. Jiang R. Gao Z. Jin Q. Wang J. Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 10223 2020 497 506 10.1016/S0140-6736(20)30183-5 31986264 

  3. 3 Liu K. Fang Y.Y. Deng Y. Liu W. Wang M.F. Ma J.P. Xiao W. Wang Y.N. Zhong M.H. Li C.H. Li G.C. Liu H.G. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province, Chin Med. J. 133 9 2020 1025 1031 10.1097/CM9.0000000000000744 

  4. 4 Xu X. Chen P. Wang J. Feng J. Zhou H. Li X. Zhong W. Hao P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission Sci. China Life Sci. 63 3 2020 457 460 10.1007/s11427-020-1637-5 32009228 

  5. 5 Khafaie M.A. Rahim F. Cross-country comparison of case fatality rates of COVID-19/SARS-COV-2 Osong Publ. Health Res. Perspect. 11 2 2020 74 80 10.24171/j.phrp.2020.11.2.03 

  6. 6 Wu J.T. Leung K. Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Lancet 395 10225 2020 689 697 10.1016/s0140-6736(20)30260-9 32014114 

  7. 7 Nkengasong J. China's response to a novel coronavirus stands in Stark contrast to the 2002 SARS outbreak response Nat. Med. 26 3 2020 310 311 10.1038/s41591-020-0771-1 31988464 

  8. 8 Li Q. Guan X. Wu P. Wang X. Zhou L. Tong Y. Ren R. Leung K.S.M. Lau E.H.Y. Wong J.Y. Xing X. Xiang N. Wu Y. Li C. Chen Q. Li D. Liu T. Zhao J. Liu M. Tu W. Chen C. Jin L. Yang R. Wang Q. Zhou S. Wang R. Liu H. Luo Y. Liu Y. Shao G. Li H. Tao Z. Yang Y. Deng Z. Liu B. Ma Z. Zhang Y. Shi G. Lam T.T.Y. Wu J.T. Gao G.F. Cowling B.J. Yang B. Leung G.M. Feng Z. Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia N. Engl. J. Med. 382 13 2020 1199 1207 10.1056/NEJMoa2001316 31995857 

  9. 9 Yang J. Zheng Y. Gou X. Pu K. Chen Z. Guo Q. Ji R. Wang H. Wang Y. Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Int. J. Infect. Dis. 94 2020 91 95 10.1016/j.ijid.2020.03.017 32173574 

  10. 10 Wu Z. McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention J. Am. Med. Assoc. 323 13 2020 1239 1242 10.1001/jama.2020.2648 

  11. 11 Wong S.H. Lui R.N. Sung J.J. Covid-19 and the digestive system J. Gastroenterol. Hepatol. 35 5 2020 744 748 10.1111/jgh.15047 32215956 

  12. 12 Lechien J.R. Chiesa-Estomba C.M. De Siati D.R. Horoi M. Le Bon S.D. Rodriguez A. Dequanter D. Blecic S. El Afia F. Distinguin L. Chekkoury-Idrissi Y. Hans S. Delgado I.L. Calvo-Henriquez C. Lavigne P. Falanga C. Barillari M.R. Cammaroto G. Khalife M. Leich P. Souchay C. Rossi C. Journe F. Hsieh J. Edjlali M. Carlier R. Ris L. Lovato A. De Filippis C. Coppee F. Fakhry N. Ayad T. Saussez S. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study Eur. Arch. Oto-Rhino-Laryngol. 277 8 2020 2251 2261 10.1007/s00405-020-05965-1 

  13. 13 Helms J. Tacquard C. Severac F. Leonard-Lorant I. Ohana M. Delabranche X. Merdji H. Clere-Jehl R. Schenck M. Fagot Gandet F. Fafi-Kremer S. Castelain V. Schneider F. Grunebaum L. Angles-Cano E. Sattler L. Mertes P.M. Meziani F. Group C.T. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study Intensive Care Med. 46 6 2020 1089 1098 10.1007/s00134-020-06062-x 32367170 

  14. 14 Baig A.M. Neurological manifestations in COVID-19 caused by SARS-CoV-2 CNS Neurosci. Ther. 26 5 2020 499 501 10.1111/cns.13372 32266761 

  15. 15 Fung T.S. Liu D.X. Human coronavirus: host-pathogen interaction Annu. Rev. Microbiol. 73 2019 529 557 10.1146/annurev-micro-020518-115759 31226023 

  16. 16 Chan J.F. To K.K. Tse H. Jin D.Y. Yuen K.Y. Interspecies transmission and emergence of novel viruses: lessons from bats and birds Trends Microbiol. 21 10 2013 544 555 10.1016/j.tim.2013.05.005 23770275 

  17. 17 Coronaviridae V. Study Group of the International Committee on Taxonomy of, the species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nat. Microbiol. 5 4 2020 536 544 10.1038/s41564-020-0695-z 32123347 

  18. 18 Liu Y. Gayle A.A. Wilder-Smith A. Rocklov J. The reproductive number of COVID-19 is higher compared to SARS coronavirus J. Trav. Med. 27 2 2020 10.1093/jtm/taaa021 

  19. 19 Bastola A. Sah R. Rodriguez-Morales A.J. Lal B.K. Jha R. Ojha H.C. Shrestha B. Chu D.K.W. Poon L.L.M. Costello A. Morita K. Pandey B.D. The first 2019 novel coronavirus case in Nepal Lancet Infect. Dis. 20 3 2020 279 280 10.1016/s1473-3099(20)30067-0 32057299 

  20. 20 Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Wang B. Xiang H. Cheng Z. Xiong Y. Zhao Y. Li Y. Wang X. Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China J. Am. Med. Assoc. 2020 10.1001/jama.2020.1585 

  21. 21 Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. Zhao X. Huang B. Shi W. Lu R. Niu P. Zhan F. Ma X. Wang D. Xu W. Wu G. Gao G.F. Tan W. China Novel Coronavirus I. Research T. A novel coronavirus from patients with pneumonia in China, 2019 N. Engl. J. Med. 382 8 2020 727 733 10.1056/NEJMoa2001017 31978945 

  22. 22 Liu Y. Yan L.M. Wan L. Xiang T.X. Le A. Liu J.M. Peiris M. Poon L.L.M. Zhang W. Viral dynamics in mild and severe cases of COVID-19 Lancet Infect. Dis. 20 6 2020 656 657 10.1016/S1473-3099(20)30232-2 32199493 

  23. 23 Cui J. Li F. Shi Z.L. Origin and evolution of pathogenic coronaviruses Nat. Rev. Microbiol. 17 3 2019 181 192 10.1038/s41579-018-0118-9 30531947 

  24. 24 de Wit E. van Doremalen N. Falzarano D. Munster V.J. SARS and MERS: recent insights into emerging coronaviruses Nat. Rev. Microbiol. 14 8 2016 523 534 10.1038/nrmicro.2016.81 27344959 

  25. 25 Liu Y. Yang Y. Zhang C. Huang F. Wang F. Yuan J. Wang Z. Li J. Li J. Feng C. Zhang Z. Wang L. Peng L. Chen L. Qin Y. Zhao D. Tan S. Yin L. Xu J. Zhou C. Jiang C. Liu L. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Sci. China Life Sci. 63 3 2020 364 374 10.1007/s11427-020-1643-8 32048163 

  26. 26 Wu A. Peng Y. Huang B. Ding X. Wang X. Niu P. Meng J. Zhu Z. Zhang Z. Wang J. Sheng J. Quan L. Xia Z. Tan W. Cheng G. Jiang T. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China Cell Host Microbe 27 3 2020 325 328 10.1016/j.chom.2020.02.001 32035028 

  27. 27 Lu R. Zhao X. Li J. Niu P. Yang B. Wu H. Wang W. Song H. Huang B. Zhu N. Bi Y. Ma X. Zhan F. Wang L. Hu T. Zhou H. Hu Z. Zhou W. Zhao L. Chen J. Meng Y. Wang J. Lin Y. Yuan J. Xie Z. Ma J. Liu W.J. Wang D. Xu W. Holmes E.C. Gao G.F. Wu G. Chen W. Shi W. Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet 395 10224 2020 565 574 10.1016/s0140-6736(20)30251-8 32007145 

  28. 28 Forster P. Forster L. Renfrew C. Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes Proc. Natl. Acad. Sci. U.S.A. 117 17 2020 9241 9243 10.1073/pnas.2004999117 32269081 

  29. 29 Chen N. Zhou M. Dong X. Qu J. Gong F. Han Y. Qiu Y. Wang J. Liu Y. Wei Y. Xia J. Yu T. Zhang X. Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 10223 2020 507 513 10.1016/S0140-6736(20)30211-7 32007143 

  30. 30 Callaway E. The race for coronavirus vaccines: a graphical guide Nature 580 7805 2020 576 577 10.1038/d41586-020-01221-y 32346146 

  31. 31 Le T.T. Cramer J.P. Chen R. Mayhew S. Evolution of the COVID-19 vaccine development landscape Nat. Rev. Drug Discov. 19 10 2020 667 668 10.1038/d41573-020-00151-8 32887942 

  32. 32 Corbett K.S. Flynn B. Foulds K.E. Francica J.R. Boyoglu-Barnum S. Werner A.P. Flach B. O'Connell S. Bock K.W. Minai M. Nagata B.M. Andersen H. Martinez D.R. Noe A.T. Douek N. Donaldson M.M. Nji N.N. Alvarado G.S. Edwards D.K. Flebbe D.R. Lamb E. Doria-Rose N.A. Lin B.C. Louder M.K. O'Dell S. Schmidt S.D. Phung E. Chang L.A. Yap C. Todd J.-P.M. Pessaint L. Van Ry A. Browne S. Greenhouse J. Putman-Taylor T. Strasbaugh A. Campbell T.-A. Cook A. Dodson A. Steingrebe K. Shi W. Zhang Y. Abiona O.M. Wang L. Pegu A. Yang E.S. Leung K. Zhou T. Teng I.T. Widge A. Gordon I. Novik L. Gillespie R.A. Loomis R.J. Moliva J.I. Stewart-Jones G. Himansu

  33. 33 Zhang N.-N. Li X.-F. Deng Y.-Q. Zhao H. Huang Y.-J. Yang G. Huang W.-J. Gao P. Zhou C. Zhang R.-R. Guo Y. Sun S.-H. Fan H. Zu S.-L. Chen Q. He Q. Cao T.-S. Huang X.-Y. Qiu H.-Y. Nie J.-H. Jiang Y. Yan H.-Y. Ye Q. Zhong X. Xue X.-L. Zha Z.-Y. Zhou D. Yang X. Wang Y.-C. Ying B. Qin C.-F. A Thermostable mRNA Vaccine against COVID-19 2020 Cell 10.1016/j.cell.2020.07.024 

  34. 34 van Doremalen N. Lambe T. Spencer A. Belij-Rammerstorfer S. Purushotham J.N. Port J.R. Avanzato V. Bushmaker T. Flaxman A. Ulaszewska M. Feldmann F. Allen E.R. Sharpe H. Schulz J. Holbrook M. Okumura A. Meade-White K. Pérez-Pérez L. Bissett C. Gilbride C. Williamson B.N. Rosenke R. Long D. Ishwarbhai A. Kailath R. Rose L. Morris S. Powers C. Lovaglio J. Hanley P.W. Scott D. Saturday G. de Wit E. Gilbert S.C. Munster V.J. ChAdOx1 nCoV-19 Vaccination Prevents SARS-CoV-2 Pneumonia in Rhesus Macaques 2020 bioRxiv 10.1101/2020.05.13.093195 

  35. 35 Ciotti M. Ciccozzi M. Terrinoni A. Jiang W.-C. Wang C.-B. Bernardini S. The COVID-19 pandemic Crit. Rev. Clin. Lab Sci. 57 6 2020 365 388 10.1080/10408363.2020.1783198 32645276 

  36. 36 Sharfstein J.M. Becker S.J. Mello M.M. Diagnostic testing for the novel coronavirus J. Am. Med. Assoc. 323 15 2020 1437 1438 10.1001/jama.2020.3864 

  37. 37 Li Y. Yao L. Li J. Chen L. Song Y. Cai Z. Yang C. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19 J. Med. Virol. 92 7 2020 903 908 10.1002/jmv.25786 32219885 

  38. 38 Liu R. Fu A. Deng Z. Li Y. Liu T. Promising methods for detection of novel coronavirus SARS‐CoV‐2 View 1 1 2020 e4 10.1002/viw2.4 

  39. 39 Rosenthal P.J. The importance of diagnostic testing during a viral pandemic: early lessons from novel coronavirus disease (COVID-19) Am. J. Trop. Med. Hyg. 102 5 2020 915 916 10.4269/ajtmh.20-0216 32238224 

  40. 40 Balboni A. Gallina L. Palladini A. Prosperi S. Battilani M. A real-time PCR assay for bat SARS-like coronavirus detection and its application to Italian greater horseshoe bat faecal sample surveys Sci. World J. 2012 2012 989514 10.1100/2012/989514 

  41. 41 Noh J.Y. Yoon S.W. Kim D.J. Lee M.S. Kim J.H. Na W. Song D. Jeong D.G. Kim H.K. Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR Arch. Virol. 162 6 2017 1617 1623 10.1007/s00705-017-3281-9 28220326 

  42. 42 Drame M. Tabue Teguo M. Proye E. Hequet F. Hentzien M. Kanagaratnam L. Godaert L. Should RT-PCR be considered a gold standard in the diagnosis of COVID-19? J. Med. Virol. 92 11 2020 2312 2313 10.1002/jmv.25996 32383182 

  43. 43 Takeuchi Y. Furuchi M. Kamimoto A. Honda K. Matsumura H. Kobayashi R. Saliva-based PCR tests for SARS-CoV-2 detection J. Oral Sci. 62 3 2020 350 351 10.2334/josnusd.20-0267 32581183 

  44. 44 Yang Y. Yang M. Shen C. Wang F. Yuan J. Li J. Zhang M. Wang Z. Xing L. Wei J. Peng L. Wong G. Zheng H. Wu W. Liao M. Feng K. Li J. Yang Q. Zhao J. Zhang Z. Liu L. Liu Y. 10.1101/2020.02.11.20021493 2020 

  45. 45 Wang W. Xu Y. Gao R. Lu R. Han K. Wu G. Tan W. Detection of SARS-CoV-2 in different types of clinical specimens J. Am. Med. Assoc. 323 18 2020 1843 1844 10.1001/jama.2020.3786 

  46. 46 Zou L. Ruan F. Huang M. Liang L. Huang H. Hong Z. Yu J. Kang M. Song Y. Xia J. Guo Q. Song T. He J. Yen H.L. Peiris M. Wu J. SARS-CoV-2 viral load in upper respiratory specimens of infected patients N. Engl. J. Med. 382 12 2020 1177 1179 10.1056/NEJMc2001737 32074444 

  47. 47 Dashraath P. Wong J.L.J. Lim M.X.K. Lim L.M. Li S. Biswas A. Choolani M. Mattar C. Su L.L. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy Am. J. Obstet. Gynecol. 2020 10.1016/j.ajog.2020.03.021 

  48. 48 Xiao A.T. Tong Y.X. Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence J. Med. Virol. 2020 10.1002/jmv.25855 

  49. 49 Chen Q. He Z. Mao F. Pei H. Cao H. Liu X. Diagnostic technologies for COVID-19: a review RSC Adv. 10 58 2020 35257 35264 10.1039/d0ra06445a 35515699 

  50. 50 van Kasteren P.B. van der Veer B. van den Brink S. Wijsman L. de Jonge J. van den Brandt A. Molenkamp R. Reusken C. Meijer A. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19 J. Clin. Virol. 128 2020 104412 10.1016/j.jcv.2020.104412 32416600 

  51. 51 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Zhang L. Fan G. Xu J. Gu X. Cheng Z. Yu T. Xia J. Wei Y. Wu W. Xie X. Yin W. Li H. Liu M. Xiao Y. Gao H. Guo L. Xie J. Wang G. Jiang R. Gao Z. Jin Q. Wang J. Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 10223 2020 497 506 10.1016/s0140-6736(20)30183-5 31986264 

  52. 52 Tahamtan A. Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results Expert Rev. Mol. Diagn. 20 5 2020 453 454 10.1080/14737159.2020.1757437 32297805 

  53. 53 Lan L. Xu D. Ye G. Xia C. Wang S. Li Y. Xu H. Positive RT-PCR test results in patients recovered from COVID-19 J. Am. Med. Assoc. 323 15 2020 1502 1503 10.1001/jama.2020.2783 

  54. 54 Arevalo-Rodriguez I. Buitrago-Garcia D. Simancas-Racines D. Zambrano-Achig P. Del Campo R. Ciapponi A. Sued O. Martinez-Garcia L. Rutjes A.W. Low N. Bossuyt P.M. Perez-Molina J.A. Zamora J. False-negative results of initial RT-PCR assays for COVID-19: a systematic review PloS One 15 12 2020 e0242958 10.1371/journal.pone.0242958 

  55. 55 Minogue T.D. Alteri C. Cento V. Antonello M. Colagrossi L. Merli M. Ughi N. Renica S. Matarazzo E. Di Ruscio F. Tartaglione L. Colombo J. Grimaldi C. Carta S. Nava A. Costabile V. Baiguera C. Campisi D. Fanti D. Vismara C. Fumagalli R. Scaglione F. Epis O.M. Puoti M. Perno C.F. Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients PloS One 15 9 2020 e0236311 10.1371/journal.pone.0236311 

  56. 56 Falzone L. Musso N. Gattuso G. Bongiorno D. Palermo C.I. Scalia G. Libra M. Stefani S. Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection Int. J. Mol. Med. 46 3 2020 957 964 10.3892/ijmm.2020.4673 32705153 

  57. 57 Brunetto G.S. Massoud R. Leibovitch E.C. Caruso B. Johnson K. Ohayon J. Fenton K. Cortese I. Jacobson S. Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations J. Neurovirol. 20 4 2014 341 351 10.1007/s13365-014-0249-3 24781526 

  58. 58 Xu M. Wang D. Wang H. Zhang X. Liang T. Dai J. Li M. Zhang J. Zhang K. Xu D. Yu X. COVID-19 diagnostic testing: technology perspective Clin. Transl. Med. 10 4 2020 e158 10.1002/ctm2.158 32898340 

  59. 59 Jiang Y. Wang H. Hao S. Chen Y. He J. Liu Y. Chen L. Yu Y. Hua S. Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications Clin. Chim. Acta 511 2020 346 351 10.1016/j.cca.2020.10.032 33159953 

  60. 60 Lu R. Wang J. Li M. Wang Y. Dong J. Cai W. SARS-CoV-2 Detection Using Digital PCR for COVID-19 Diagnosis, Treatment Monitoring and Criteria for Discharge 2020 medRxiv 10.1101/2020.03.24.20042689 

  61. 61 Suo T. Liu X. Feng J. Guo M. Hu W. Guo D. Ullah H. Yang Y. Zhang Q. Wang X. Sajid M. Huang Z. Deng L. Chen T. Liu F. Xu K. Liu Y. Zhang Q. Liu Y. Xiong Y. Chen G. Lan K. Chen Y. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens Emerg. Microb. Infect. 9 1 2020 1259 1268 10.1080/22221751.2020.1772678 

  62. 62 Levy S.E. Myers R.M. Advancements in next-generation sequencing Annu. Rev. Genom. Hum. Genet. 17 2016 95 115 10.1146/annurev-genom-083115-022413 

  63. 63 Maljkovic Berry I. Melendrez M.C. Bishop-Lilly K.A. Rutvisuttinunt W. Pollett S. Talundzic E. Morton L. Jarman R.G. Next generation sequencing and bioinformatics methodologies for infectious disease research and public health: approaches, applications, and considerations for development of laboratory capacity J. Infect. Dis. 221 Suppl 3 2020 S292 S307 10.1093/infdis/jiz286 31612214 

  64. 64 J.T. Burger, H.J. Maree, Metagenomic Next-Generation Sequencing of Viruses Infecting Grapevines, Plant Pathol., Springer2015, pp. 315-330. 

  65. 65 LeMieux J. Moving beyond PCR: next-generation sequencing enters the COVID-19 testing arena Clinical OMICs 7 4 2020 12 15 10.1089/clinomi.07.04.18 

  66. 66 Gu W. Deng X. Lee M. Sucu Y.D. Arevalo S. Stryke D. Federman S. Gopez A. Reyes K. Zorn K. Sample H. Yu G. Ishpuniani G. Briggs B. Chow E.D. Berger A. Wilson M.R. Wang C. Hsu E. Miller S. DeRisi J.L. Chiu C.Y. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids Nat. Med. 27 1 2020 115 124 10.1038/s41591-020-1105-z 33169017 

  67. 67 Minucci A. Scambia G. Santonocito C. Concolino P. Urbani A. BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic Mol. Biol. Rep. 47 6 2020 4857 4860 10.1007/s11033-020-05479-3 32388698 

  68. 68 Sauter J.L. Baine M.K. Butnor K.J. Buonocore D.J. Chang J.C. Jungbluth A.A. Szabolcs M.J. Morjaria S. Mount S.L. Rekhtman N. Selbs E. Sheng Z.M. Xiao Y. Kleiner D.E. Pittaluga S. Taubenberger J.K. Rapkiewicz A.V. Travis W.D. Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies Histopathology 77 6 2020 915 925 10.1111/his.14201 32614086 

  69. 69 Bal A. Destras G. Gaymard A. Bouscambert-Duchamp M. Valette M. Escuret V. Frobert E. Billaud G. Trouillet-Assant S. Cheynet V. Brengel-Pesce K. Morfin F. Lina B. Josset L. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del) Clin. Microbiol. Infect. 26 7 2020 960 962 10.1016/j.cmi.2020.03.020 32234449 

  70. 70 Moore S.C. Penrice-Randal R. Alruwaili M. Dong X. Pullan S.T. Carter D.P. Bewley K. Zhao Q. Sun Y. Hartley C. Zhou E.-m. Solomon T. Beadsworth M.B.J. Cruise J. Bogaert D. Crook D.W. Matthews D.A. Davidson A.D. Mahmood Z. Aljabr W. Druce J. Vipond R.T. Ng L.F.P. Renia L. Openshaw P.J.M. Baillie J.K. Carroll M.W. Semple M.G. Turtle L. Hiscox J.A. Amplicon Based MinION Sequencing of SARS-CoV-2 and Metagenomic Characterisation of Nasopharyngeal Swabs from Patients with COVID-19 2020 medRxiv 10.1101/2020.03.05.20032011 

  71. 71 Li N. Cai Q. Miao Q. Song Z. Fang Y. Hu B. High‐throughput metagenomics for identification of pathogens in the clinical settings Small Method. 5 1 2020 10.1002/smtd.202000792 

  72. 72 Ji T. Liu Z. Wang G. Guo X. Akbar Khan S. Lai C. Chen H. Huang S. Xia S. Chen B. Jia H. Chen Y. Zhou Q. Detection of COVID-19: a review of the current literature and future perspectives Biosens. Bioelectron. 166 2020 112455 10.1016/j.bios.2020.112455 32739797 

  73. 73 Munoz H.E. Riche C.T. Kong J.E. van Zee M. Garner O.B. Ozcan A. Di Carlo D. Fractal L.A.M.P. Label-free analysis of fractal precipitate for digital loop-mediated isothermal nucleic acid amplification ACS Sens. 5 2 2020 385 394 10.1021/acssensors.9b01974 31902202 

  74. 74 Carter L.J. Garner L.V. Smoot J.W. Li Y. Zhou Q. Saveson C.J. Sasso J.M. Gregg A.C. Soares D.J. Beskid T.R. Jervey S.R. Liu C. Assay techniques and test development for COVID-19 diagnosis ACS Cent. Sci. 6 5 2020 591 605 10.1021/acscentsci.0c00501 32382657 

  75. 75 Verma G. Raigond B. Pathania S. Kochhar T. Naga K. Development and comparison of reverse transcription-loop-mediated isothermal amplification assay (RT-LAMP), RT-PCR and real time PCR for detection of Potato spindle tuber viroid in potato Eur. J. Plant Pathol. 158 4 2020 951 964 10.1007/s10658-020-02129-z 

  76. 76 Dao Thi V.L. Herbst K. Boerner K. Meurer M. Kremer L.P. Kirrmaier D. Freistaedter A. Papagiannidis D. Galmozzi C. Stanifer M.L. Boulant S. Klein S. Chlanda P. Khalid D. Barreto Miranda I. Schnitzler P. Krausslich H.G. Knop M. Anders S. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples Sci. Transl. Med. 12 556 2020 10.1126/scitranslmed.abc7075 

  77. 77 Jiang M. Pan W. Arasthfer A. Fang W. Ling L. Fang H. Daneshnia F. Yu J. Liao W. Pei H. Li X. Lass-Flörl C. Development and validation of a rapid, single-step reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) system potentially to Be used for reliable and high-throughput screening of COVID-19 Front. Cell. Infect. Microbiol. 10 2020 10.3389/fcimb.2020.00331 

  78. 78 Yu L. Wu S. Hao X. Dong X. Mao L. Pelechano V. Chen W.H. Yin X. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform Clin. Chem. 66 7 2020 975 977 10.1093/clinchem/hvaa102 32315390 

  79. 79 Li S.Y. Cheng Q.X. Liu J.K. Nie X.Q. Zhao G.P. Wang J. CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA Cell Res. 28 4 2018 491 493 10.1038/s41422-018-0022-x 29531313 

  80. 80 Chen J.S. Ma E. Harrington L.B. Da Costa M. Tian X. Palefsky J.M. Doudna J.A. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity Science 360 6387 2018 436 439 10.1126/science.aar6245 29449511 

  81. 81 Ding X. Yin K. Li Z. Lalla R.V. Ballesteros E. Sfeir M.M. Liu C. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay Nat. Commun. 11 1 2020 4711 10.1038/s41467-020-18575-6 32948757 

  82. 82 Broughton J.P. Deng X. Yu G. Fasching C.L. Servellita V. Singh J. Miao X. Streithorst J.A. Granados A. Sotomayor-Gonzalez A. Zorn K. Gopez A. Hsu E. Gu W. Miller S. Pan C.Y. Guevara H. Wadford D.A. Chen J.S. Chiu C.Y. CRISPR-Cas12-based detection of SARS-CoV-2 Nat. Biotechnol. 38 7 2020 870 874 10.1038/s41587-020-0513-4 32300245 

  83. 83 Joung J. Ladha A. Saito M. Segel M. Bruneau R. Huang M.W. Kim N.G. Yu X. Li J. Walker B.D. Greninger A.L. Jerome K.R. Gootenberg J.S. Abudayyeh O.O. Zhang F. Point-of-care Testing for COVID-19 Using SHERLOCK Diagnostics 2020 medRxiv 10.1101/2020.05.04.20091231 

  84. 84 Stowell S.R. Guarner J. Role of serology in the coronavirus disease 2019 pandemic Clin. Infect. Dis. 71 8 2020 1935 1936 10.1093/cid/ciaa510 32357206 

  85. 85 Theel E.S. Slev P. Wheeler S. Couturier M.R. Wong S.J. Kadkhoda K. The role of antibody testing for SARS-CoV-2: is there one? J. Clin. Microbiol. 58 8 2020 10.1128/JCM.00797-20 

  86. 86 Yuan M. Liu H. Wu N.C. Lee C.D. Zhu X. Zhao F. Huang D. Yu W. Hua Y. Tien H. Rogers T.F. Landais E. Sok D. Jardine J.G. Burton D.R. Wilson I.A. Structural basis of a shared antibody response to SARS-CoV-2 Science 2020 10.1126/science.abd2321 

  87. 87 Long Q.-x. Deng H.-j. Chen J. Hu J.-l. Liu B.-z. Liao P. Lin Y. Yu L.-h. Mo Z. Xu Y.-y. Gong F. Wu G.-c. Zhang X.-x. Chen Y.-k. Li Z.-j. Wang K. Zhang X.-l. Tian W.-g. Niu C.-c. Yang Q.-j. Xiang J.-l. Du H.-x. Liu H.-w. Lang C.-h. Luo X.-H. Wu S.-b. Cui X.-p. Zhou Z. Wang J. Xue C.-j. Li X.-f. Wang L. Tang X.-j. Zhang Y. Qiu J.-f. Liu X.-m. Li J.-j. Zhang D.-c. Zhang F. Cai X.-f. Wang D.-q. Hu Y. Ren J.-h. Tang N. Liu P. Li Q. Huang A.-l. Antibody Responses to SARS-CoV-2 in COVID-19 Patients: the Perspective Application of Serological Tests in Clinical Practice MedRxiv 2020 10.1101/2020.03.18.20038018 

  88. 88 Boyle M.J. Chan J.A. Handayuni I. Reiling L. Feng G. Hilton A. Kurtovic L. Oyong D. Piera K.A. Barber B.E. William T. Eisen D.P. Minigo G. Langer C. Drew D.R. de Labastida Rivera F. Amante F.H. Williams T.N. Kinyanjui S. Marsh K. Doolan D.L. Engwerda C. Fowkes F.J.I. Grigg M.J. Mueller I. McCarthy J.S. Anstey N.M. Beeson J.G. IgM in human immunity to Plasmodium falciparum malaria Sci Adv 5 9 2019 eaax4489 10.1126/sciadv.aax4489 

  89. 89 ≤cid%2Fciaa523.pdf>. 10.1093/cid/ciaa523/5827750 . 

  90. 90 Zhang Z.L. Hou Y.L. Li D.T. Li F.Z. Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for COVID-19: a meta-analysis J. Med. Virol. 93 1 2021 366 374 10.1002/jmv.26211 32568413 

  91. 91 Jacofsky D. Jacofsky E.M. Jacofsky M. Understanding antibody testing for COVID-19 J. Arthroplasty 35 7S 2020 S74 S81 10.1016/j.arth.2020.04.055 32389405 

  92. 92 To K.K.-W. Tsang O.T.-Y. Leung W.-S. Tam A.R. Wu T.-C. Lung D.C. Yip C.C.-Y. Cai J.-P. Chan J.M.-C. Chik T.S.-H. Lau D.P.-L. Choi C.Y.-C. Chen L.-L. Chan W.-M. Chan K.-H. Ip J.D. Ng A.C.-K. Poon R.W.-S. Luo C.-T. Cheng V.C.-C. Chan J.F.-W. Hung I.F.-N. Chen Z. Chen H. Yuen K.-Y. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Lancet Infect. Dis. 20 5 2020 565 574 10.1016/s1473-3099(20)30196-1 32213337 

  93. 93 Berthoud O. Coiffier G. Albert J.D. Gougeon-Jolivet A. Goussault C. Bendavid C. Guggenbuhl P. Performance of a new rapid diagnostic test the lactate/glucose ratio of synovial fluid for the diagnosis of septic arthritis Joint Bone Spine 87 4 2020 343 350 10.1016/j.jbspin.2020.03.009 32234547 

  94. 94 Posthuma-Trumpie G.A. Korf J. van Amerongen A. Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey Anal. Bioanal. Chem. 393 2 2009 569 582 10.1007/s00216-008-2287-2 18696055 

  95. 95 Bahadır E.B. Sezgintürk M.K. Lateral flow assays: principles, designs and labels TrAC Trends Anal. Chem. (Reference Ed.) 82 2016 286 306 10.1016/j.trac.2016.06.006 

  96. 96 Zuo J.Y. Jiao Y.J. Zhu J. Ding S.N. Rapid detection of severe fever with thrombocytopenia syndrome virus via colloidal gold immunochromatography assay ACS Omega 3 11 2018 15399 15406 10.1021/acsomega.8b02366 30556007 

  97. 97 Ge X. Zhang W. Lin Y. Du D. Magnetic Fe3O4@TiO2 nanoparticles-based test strip immunosensing device for rapid detection of phosphorylated butyrylcholinesterase Biosens. Bioelectron. 50 2013 486 491 10.1016/j.bios.2013.07.017 23911770 

  98. 98 Lu T. Zhu K.D. Huang C. Wen T. Jiao Y.J. Zhu J. Zhang Q. Ding S.N. Rapid detection of Shiga toxin type II using lateral flow immunochromatography test strips of colorimetry and fluorimetry Analyst 145 1 2019 76 82 10.1039/c9an01996k 31748765 

  99. 99 Pan Y. Li X. Yang G. Fan J. Tang Y. Zhao J. Long X. Guo S. Zhao Z. Liu Y. Hu H. Xue H. Li Y. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients J. Infect. 81 1 2020 e28 e32 10.1016/j.jinf.2020.03.051 

  100. 100 Hu X. Wu C. Situ B. Tian P. An T. Li Q. Pan W. Zhang R. Yang B. Sun D. Hu Y. Wang Q. Zheng L. EDTA-K2 improves the detection sensitivity of SARS-CoV-2 IgM and IgG antibodies by chelating colloidal gold in the immunochromatographic assay Int. J. Nanomed. 16 2021 715 724 10.2147/ijn.S281594 

  101. 101 Liu C. Mao B. Martinez V. Chen X. Li Y. He L. Chen S. Guo X. Shen X. Bao X. Shen H. Lenna S. Qian P. Wu L. Li C. A facile assay for rapid detection of COVID-19 antibodies RSC Adv. 10 47 2020 28041 28048 10.1039/d0ra04107f 35519100 

  102. 102 Vilela D. Gonzalez M.C. Escarpa A. Sensing colorimetric approaches based on gold and silver nanoparticles aggregation: chemical creativity behind the assay. A review Anal. Chim. Acta 751 2012 24 43 10.1016/j.aca.2012.08.043 23084049 

  103. 103 Huang C. Wen T. Shi F.J. Zeng X.Y. Jiao Y.J. Rapid detection of IgM antibodies against the SARS-CoV-2 virus via colloidal gold nanoparticle-based lateral-flow assay ACS Omega 5 21 2020 12550 12556 10.1021/acsomega.0c01554 32542208 

  104. 104 Kaneko S. Nukui Y. Arashiro T. Aiso Y. Sugii M. Hadano Y. Nagata K. Taki R. Ueda K. Hanada S. Suzaki S. Harada N. Yamaguchi Y. Nakanishi H. Kurosaki M. Nagasawa M. Izumi N. Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort J. Med. Virol. 2020 10.1002/jmv.26363 

  105. 105 Xiang J. Yan M. Li H. Liu T. Lin C. Huang S. Shen C. Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold-Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19) MedRxiv 2020 10.1101/2020.02.27.20028787 

  106. 106 Dorschug A. Schwanbeck J. Hahn A. Hillebrecht A. Blaschke S. Gross U. Heimesaat M.M. Frickmann H. Zautner A.E. Evaluation of the Xiamen Amon Med Biotechnology rapid diagnostic test COVID-19 IgM/IgG test kit (Colloidal gold) Eur. J. Microbiol. Immunol. (Bp) 10 3 2020 178 185 10.1556/1886.2020.00029 32979256 

  107. 107 Rai P. Kumar B.K. Deekshit V.K. Karunasagar I. Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection Appl. Microbiol. Biotechnol. 105 2 2021 441 455 10.1007/s00253-020-11061-5 33394144 

  108. 108 Infantino M. Grossi V. Lari B. Bambi R. Perri A. Manneschi M. Terenzi G. Liotti I. Ciotta G. Taddei C. Benucci M. Casprini P. Veneziani F. Fabbri S. Pompetti A. Manfredi M. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience J. Med. Virol. 92 9 2020 1671 1675 10.1002/jmv.25932 32330291 

  109. 109 Soleimani R. Khourssaji M. Gruson D. Rodriguez‐Villalobos H. Berghmans M. Belkhir L. Yombi J.C. Kabamba‐Mukadi B. Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID‐19 patients J. Med. Virol. 93 3 2020 1465 1477 10.1002/jmv.26430 32797641 

  110. 110 Padoan A. Cosma C. Sciacovelli L. Faggian D. Plebani M. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics Clin. Chem. Lab. Med. 58 7 2020 1081 1088 10.1515/cclm-2020-0443 32301749 

  111. 111 Gong F. Dai Y. Zheng T. Cheng L. Zhao D. Wang H. Liu M. Pei H. Jin T. Yu D. Zhou P. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals J. Clin. Invest. 130 12 2020 6588 6599 10.1172/JCI141054 32841212 

  112. 112 Boguszewska K. Szewczuk M. Urbaniak S. Karwowski B.T. Review: immunoassays in DNA damage and instability detection Cell. Mol. Life Sci. 76 23 2019 4689 4704 10.1007/s00018-019-03239-6 31342119 

  113. 113 Kong W.H. Li Y. Peng M.W. Kong D.G. Yang X.B. Wang L. Liu M.Q. SARS-CoV-2 detection in patients with influenza-like illness Nat. Microbiol. 5 5 2020 675 678 10.1038/s41564-020-0713-1 32265517 

  114. 114 Li X. Geng M. Peng Y. Meng L. Lu S. Molecular immune pathogenesis and diagnosis of COVID-19 J Pharm Anal. 10 2 2020 102 108 10.1016/j.jpha.2020.03.001 32282863 

  115. 115 Wang Y. Wang Y. Chen Y. Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures J. Med. Virol. 92 6 2020 568 576 10.1002/jmv.25748 32134116 

  116. 116 Van Elslande J. Houben E. Depypere M. Brackenier A. Desmet S. Andre E. Van Ranst M. Lagrou K. Vermeersch P. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients Clin. Microbiol. Infect. 26 8 2020 1082 1087 10.1016/j.cmi.2020.05.023 32473953 

  117. 117 Kovac M. Risch L. Thiel S. Weber M. Grossmann K. Wohlwend N. Lung T. Hillmann D. Ritzler M. Bigler S. Ferrara F. Bodmer T. Egli K. Imperiali M. Heer S. Salimi Y. Renz H. Kohler P. Vernazza P. Kahlert C.R. Paprotny M. Risch M. EDTA-anticoagulated whole blood for SARS-CoV-2 antibody testing by electrochemiluminescence immunoassay (ECLIA) and enzyme-linked immunosorbent assay (ELISA) Diagnostics 10 8 2020 10.3390/diagnostics10080593 

  118. 118 Tayyab M. Sami M.A. Raji H. Mushnoori S. Javanmard M. Potential microfluidic devices for COVID-19 antibody detection at point-of-care (POC): a review IEEE Sensor. J. 21 4 2021 4007 4017 10.1109/jsen.2020.3034892 

  119. 119 Kontou P.I. Braliou G.G. Dimou N.L. Nikolopoulos G. Bagos P.G. Antibody tests in detecting SARS-CoV-2 infection: a meta-analysis Diagnostics 10 5 2020 10.3390/diagnostics10050319 

  120. 120 Shi H. Han X. Jiang N. Cao Y. Alwalid O. Gu J. Fan Y. Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Lancet Infect. Dis. 20 4 2020 425 434 10.1016/s1473-3099(20)30086-4 32105637 

  121. 121 Koo H.J. Lim S. Choe J. Choi S.-H. Sung H. Do K.-H. Radiographic and CT features of viral pneumonia Radiographics 38 3 2018 719 739 10.1148/rg.2018170048 29757717 

  122. 122 Ng M.-Y. Lee E.Y.P. Yang J. Yang F. Li X. Wang H. Lui M.M.-s. Lo C.S.-Y. Leung B. Khong P.-L. Hui C.K.-M. Yuen K.-y. Kuo M.D. Imaging profile of the COVID-19 infection: radiologic findings and literature review Radiology: Cardiothor. Imag. 2 1 2020 10.1148/ryct.2020200034 

  123. 123 Wang S. Kang B. Ma J. Zeng X. Xiao M. Guo J. Cai M. Yang J. Li Y. Meng X.J.M. A Deep Learning Algorithm Using CT Images to Screen for Corona Virus Disease (COVID-19) 2020 medRxiv 10.1101/2020.02.14.20023028 

  124. 124 Mei X. Lee H.C. Diao K.Y. Huang M. Lin B. Liu C. Xie Z. Ma Y. Robson P.M. Chung M. Bernheim A. Mani V. Calcagno C. Li K. Li S. Shan H. Lv J. Zhao T. Xia J. Long Q. Steinberger S. Jacobi A. Deyer T. Luksza M. Liu F. Little B.P. Fayad Z.A. Yang Y. Artificial intelligence-enabled rapid diagnosis of patients with COVID-19 Nat. Med. 2020 10.1038/s41591-020-0931-3 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로